Information on medicines used to treat COVID-19
VicTAG have endorsed the NSW TAG developed Patient and Family Information Leaflets and Consent forms, for medicines used to treat COVID-19, for use in Victorian hospitals. Documents endorsed for use contain the VicTAG logo.
The documents can be found on the NSW TAG COVID-19 Resources webpage.
Currently both Patient and Family Information Leaflets and Consent forms are available for:
- baricitinib
- remdesivir
- sotrovimab
- tocilizumab
- sarilumab